Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human/Mouse/Rat MOG Antibody (8-18C5), PE

Catalog #:   FRH33512 Specific References (100) DATASHEET
Host species: Human
Isotype: IgG1, kappa
Applications: ELISA, FCM, IF, WB
Accession: Q63345
Overview

Catalog No.

FRH33512

Species reactivity

Human, Mouse, Rat, Bovine

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

PE

Target

MOG, Myelin-oligodendrocyte glycoprotein

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

Q63345

Applications

ELISA, FCM, IF, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

8-18C5

Data Image
References

Relapsing anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder diagnosed double positive for anti-myelin oligodendrocyte glycoprotein antibody., PMID:40506104

Relapsing anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder diagnosed double positive for anti-myelin oligodendrocyte glycoprotein antibody., PMID:40506104

Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders., PMID:40505071

Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders., PMID:40505071

Unmasking Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): CNS Demyelination Triggered by TNF-α Inhibition in a Patient with Ankylosing Spondylitis., PMID:40502939

Unmasking Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): CNS Demyelination Triggered by TNF-α Inhibition in a Patient with Ankylosing Spondylitis., PMID:40502939

The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD., PMID:40495001

The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD., PMID:40495001

French guidelines for the diagnostic and management of MOG antibody-associated disease., PMID:40494723

French guidelines for the diagnostic and management of MOG antibody-associated disease., PMID:40494723

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort., PMID:40485599

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort., PMID:40485599

Tumefactive demyelination as the first presentation of MOG ab-associated disease., PMID:40479755

Tumefactive demyelination as the first presentation of MOG ab-associated disease., PMID:40479755

Acute bilateral optic/chiasm neuritis with longitudinally extensive transverse myelitis and positive anti-ganglioside antibodies following mycoplasma pneumoniae pneumonia: a case report and literature review., PMID:40471512

Acute bilateral optic/chiasm neuritis with longitudinally extensive transverse myelitis and positive anti-ganglioside antibodies following mycoplasma pneumoniae pneumonia: a case report and literature review., PMID:40471512

Clinical, imaging, and recurrence analysis of myelin oligodendrocyte glycoprotein antibody-associated disease with initial presentation as meningoencephalitis in children: a single-center retrospective study., PMID:40464908

Clinical, imaging, and recurrence analysis of myelin oligodendrocyte glycoprotein antibody-associated disease with initial presentation as meningoencephalitis in children: a single-center retrospective study., PMID:40464908

Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation., PMID:40463369

Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation., PMID:40463369

Clinical Spectrum of Acquired Demyelinating Syndromes in Children: A Tertiary Hospital Experience., PMID:40461933

Clinical Spectrum of Acquired Demyelinating Syndromes in Children: A Tertiary Hospital Experience., PMID:40461933

Clinical characteristics of antibody reaction to P42 epitope profiles in myelin oligodendrocyte glycoprotein antibody-associated disorders among a Chinese population., PMID:40450827

Clinical characteristics of antibody reaction to P42 epitope profiles in myelin oligodendrocyte glycoprotein antibody-associated disorders among a Chinese population., PMID:40450827

From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis., PMID:40447786

From checkboxes to emojis: a novel approach to patient-reported outcomes in multiple sclerosis., PMID:40447786

Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis., PMID:40446499

Clinical presentation, MR imaging and outcome in children with myelin oligodendrocyte glycoprotein antibody-negative acute disseminated encephalomyelitis., PMID:40446499

Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study., PMID:40446185

Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study., PMID:40446185

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445

Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445

Coexistence of anti-MOG and anti-MAG antibodies in combined central and peripheral nervous system demyelination: a case of dual myelinopathy., PMID:40418511

Coexistence of anti-MOG and anti-MAG antibodies in combined central and peripheral nervous system demyelination: a case of dual myelinopathy., PMID:40418511

Impact of Anti-MOG Antibody in Diagnosis of Autoimmune Diseases of the Central Nervous System in Children: A Case Series., PMID:40409277

Impact of Anti-MOG Antibody in Diagnosis of Autoimmune Diseases of the Central Nervous System in Children: A Case Series., PMID:40409277

Pediatric Anti-MOG Antibody-Associated Disease (MOGAD) with Coexisting Myasthenia Gravis: A Rare Association., PMID:40394730

Pediatric Anti-MOG Antibody-Associated Disease (MOGAD) with Coexisting Myasthenia Gravis: A Rare Association., PMID:40394730

Disrupted static and dynamic Large-scale brain functional network connectivity in the differentiation of myelin oligodendrocyte glycoprotein Antibody-Seropositive from seronegative optic neuritis., PMID:40392288

Disrupted static and dynamic Large-scale brain functional network connectivity in the differentiation of myelin oligodendrocyte glycoprotein Antibody-Seropositive from seronegative optic neuritis., PMID:40392288

Atypical Autoimmune Encephalitis: Diagnostic Challenges and Therapeutic Insights From a Case Series., PMID:40385909

Atypical Autoimmune Encephalitis: Diagnostic Challenges and Therapeutic Insights From a Case Series., PMID:40385909

Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in Japan., PMID:40377800

Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in Japan., PMID:40377800

Reply to Letter: Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based Assay., PMID:40368601

Reply to Letter: Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based Assay., PMID:40368601

Letter to: Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based Assay., PMID:40368592

Letter to: Real-World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell-Based Assay., PMID:40368592

Coronavirus Disease 2019 Infection and Vaccination in Pediatric Demyelinating Diseases., PMID:40367669

Coronavirus Disease 2019 Infection and Vaccination in Pediatric Demyelinating Diseases., PMID:40367669

Acute Disseminated Encephalomyelitis in Children and Adolescents: A Multicenter Retrospective Study of Relapse and Outcome., PMID:40340642

Acute Disseminated Encephalomyelitis in Children and Adolescents: A Multicenter Retrospective Study of Relapse and Outcome., PMID:40340642

Seronegative Autoimmune Encephalomyelitis with Area Postrema Symptoms., PMID:40336575

Seronegative Autoimmune Encephalomyelitis with Area Postrema Symptoms., PMID:40336575

CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease., PMID:40332104

CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease., PMID:40332104

Herpes Zoster Myelitis Mimicking Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease: A Case Report., PMID:40330417

Herpes Zoster Myelitis Mimicking Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease: A Case Report., PMID:40330417

The "H sign" in MOGAD myelitis., PMID:40327177

The "H sign" in MOGAD myelitis., PMID:40327177

Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:40324120

Clinical Features and Factors Associated With Outcome in Late Adult-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:40324120

Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies., PMID:40317881

Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies., PMID:40317881

MOG positive primary autoimmune meningitis mimicking tuberculous meningitis: a case series., PMID:40297746

MOG positive primary autoimmune meningitis mimicking tuberculous meningitis: a case series., PMID:40297746

Assessing fall risk in multiple sclerosis using patient-reported outcomes and wearable gait metrics., PMID:40292035

Assessing fall risk in multiple sclerosis using patient-reported outcomes and wearable gait metrics., PMID:40292035

Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter study., PMID:40288332

Clinical characteristics and outcome of double-AQP4/MOG-seronegative and not MS-associated monophasic and relapsing demyelinating transverse myelitis: A monocenter study., PMID:40288332

Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study., PMID:40281286

Multimodal prognostication of autoimmune encephalitis: an Australian autoimmune encephalitis consortium study., PMID:40281286

Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches., PMID:40274184

Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches., PMID:40274184

MOG antibody-positive patients meeting diagnostic criteria for MS: is it MOGAD with an MS-like phenotype or true MS?, PMID:40266423

MOG antibody-positive patients meeting diagnostic criteria for MS: is it MOGAD with an MS-like phenotype or true MS?, PMID:40266423

A case of acute macular neuroretinopathy in a pediatric patient with optic neuritis., PMID:40265085

A case of acute macular neuroretinopathy in a pediatric patient with optic neuritis., PMID:40265085

T cells in ARAP-deficient mice present defective T cell receptor signaling and reduced severity in an experimentally-induced autoimmune disease., PMID:40264755

T cells in ARAP-deficient mice present defective T cell receptor signaling and reduced severity in an experimentally-induced autoimmune disease., PMID:40264755

Lumbosacral dura mater and cauda equina lesions in MOG antibody-associated disease., PMID:40257528

Lumbosacral dura mater and cauda equina lesions in MOG antibody-associated disease., PMID:40257528

Clinical utility of complete blood count indices in pediatric MOG antibody-associated disease., PMID:40253903

Clinical utility of complete blood count indices in pediatric MOG antibody-associated disease., PMID:40253903

Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report., PMID:40244463

Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report., PMID:40244463

Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease., PMID:40234072

Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease., PMID:40234072

A case of MOGAD with rectal adenocarcinoma: Comorbidity or paraneoplastic neurological syndrome?, PMID:40231213

A case of MOGAD with rectal adenocarcinoma: Comorbidity or paraneoplastic neurological syndrome?, PMID:40231213

Leber Hereditary Optic Neuropathy With Magnetic Resonance Imaging Findings Suggestive of Optic Perineuritis and Optic Neuritis: A Diagnostic Challenge., PMID:40225540

Leber Hereditary Optic Neuropathy With Magnetic Resonance Imaging Findings Suggestive of Optic Perineuritis and Optic Neuritis: A Diagnostic Challenge., PMID:40225540

The utility of serum neurofilament light chain in MOGAD: Current insights and future directions., PMID:40220725

The utility of serum neurofilament light chain in MOGAD: Current insights and future directions., PMID:40220725

Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study., PMID:40217895

Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study., PMID:40217895

MOG-Encephalitis is the Most Prevalent Autoimmune Encephalitis in Children: MERIN Study Data on Encephalitis., PMID:40209801

MOG-Encephalitis is the Most Prevalent Autoimmune Encephalitis in Children: MERIN Study Data on Encephalitis., PMID:40209801

Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis., PMID:40206289

Electroencephalographic biomarkers of antibody-mediated autoimmune encephalitis., PMID:40206289

Datasheet
$ 292
Product specifications
50 T 292 100 T 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human/Mouse/Rat MOG Antibody (8-18C5), PE [FRH33512]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only